Topics: ACTA
Events
-
-
Clinical Trials 2022: National Tribute and Awards
-
ACTA STInG 3 part webinar series on Data Transparency (DT)
-
Sector consultations – online discussion with ACTA
-
Clinical Trials 2020: National Tribute and Award Ceremony
-
ACTA CEO update – October 2022
-
ACTA Advisory Council
-
Economic evaluation alongside cluster trial webinar
-
ACTA CEO update – August 2022
-
ACTA Summit and Clinical Trials 2020 National Tribute and Award Ceremony
-
Clinical Quality Registries (CQR) SIG member webinar – Oct 2022
-
ACTA International Clinical Trials Conference 2 – 5 October 2019
-
Clinical Trials (CT) Socials
-
Improving clinical trial recruitment through innovative technologies
-
Economic Evaluation Alongside Adaptive Trials webinar – 22 November
-
ACTA Annual General Meeting
-
2022 ACTA ASM including the Australian Registry ASM
News
-
International leaders in Clinical Trials meet in Sydney
-
Health Economics 101 – designing cost-effectiveness studies alongside trials
-
Call for new Members for ACTA’s Reference Groups
-
Pre-Conference workshops
-
All.Can cancer survey highlights patient experience
-
Accolades for Australian clinical trials at annual ACTA awards
-
ACTA’s response to the October 2022 budget announcements
-
ACTA Teletrials Project – CTN and CC survey
-
Conference speaker and Executive Director of CTTI releases recommendations for mobile technology trials
-
ACTA on Christmas break
-
ACTA celebrates successful International Clinical Trials Conference
-
Federal Minister for Health opening ACTA International Clinical Trials Conference
-
ACTA moving to virtual meetings in response to COVID-19
-
Australian Clinical Trials Alliance appoints Prof Steve Webb as its new Chair and Ian Wilson as Additional Independent Director
-
Report update: Clinical trials landscape in Australia (2006 – 2020)
-
Workshop: Pragmatic randomised trial designs for evaluating health policy and practice change interventions
-
ACTA website survey
-
ACTA—a year in review, 2018-2019 financial year
-
MRFF Australian Medical Research and Innovation Strategy and Priorities consultation and newly appointed Australian Medical Research Advisory Board